Showing results (71-80 of 252) with videos related to

Sort By:
Pageof 26
Hepatology Communications|January 24, 2023
Autopsy histology data suggest cirrhosis is frequently under-reported on death certificatesHannes Hagström, Tracey G Simon, Jonas Söderling, et al.
Gastroenterology|September 30, 2019
Ability of Noninvasive Scoring Systems to Identify Individuals in the Population at Risk for Severe Liver DiseaseHannes Hagström, Mats Talbäck, Anna Andreasson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Biomarkers for Prediction of Alcohol-Related Liver Cirrhosis: A General Population-Based Swedish Study of 537,250 IndividualsGustav Jakobsson, Mats Talbäck, Niklas Hammar, et al.
Scandinavian Journal of Gastroenterology|October 9, 2024
The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general populationChristina Villard, Linnea Widman, Ernesto Sparrelid, et al.
Scandinavian Journal of Gastroenterology|September 29, 2025
Risk of tumour recurrence following curative treatment of hepatocellular carcinomaBonnie Bengtsson, Gustaf Pak, Juan Vaz, et al.
Scandinavian Journal of Gastroenterology|May 23, 2022
Hepatocellular carcinoma in Stockholm, Sweden 2003-2018: a population-based cohort studySanna Norén, Bonnie Bengtsson, Hannes Hagström, et al.
Scandinavian Journal of Gastroenterology|September 21, 2017
IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot studyHannes Hagström, Per Stål, Rolf Hultcrantz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 5, 2019
Characteristics and outcome of hepatocellular carcinoma in patients with NAFLD without cirrhosisBonnie Bengtsson, Per Stål, Staffan Wahlin, et al.
Plos One|August 24, 2018
Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-upHannes Hagström, Anna Andreasson, Axel C Carlsson, et al.
Frontiers in Immunology|June 21, 2023
Dysregulated peripheral proteome reveals NASH-specific signatures identifying patient subgroups with distinct liver biologyNatalie Stiglund, Hannes Hagström, Per Stål, et al.
Pageof 26